Clinical trial

Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy

NCT05620641

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-10-01

PhasePHASE3

Study timeline

Study start (actual)2022-10-01Date precision: day

Registry last updated2025-04-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Post Operative Nausea and Vomitingunresolved

Sleeve Gastrectomyunresolved

Morbid Obesityunresolved

Interventions

Ondansetron 8mgDRUG

GabapentinDRUG · verified · RxNorm: gabapentin

Sponsors & collaborators

Tanta Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05620641 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.